139 related articles for article (PubMed ID: 8382319)
1. Efficient analysis of nonviable poliovirus capsid mutants.
Simons J; Rogove A; Moscufo N; Reynolds C; Chow M
J Virol; 1993 Mar; 67(3):1734-8. PubMed ID: 8382319
[TBL] [Abstract][Full Text] [Related]
2. Myristate-protein interactions in poliovirus: interactions of VP4 threonine 28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions.
Moscufo N; Chow M
J Virol; 1992 Dec; 66(12):6849-57. PubMed ID: 1331497
[TBL] [Abstract][Full Text] [Related]
3. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
Ansardi DC; Porter DC; Morrow CD
J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
[TBL] [Abstract][Full Text] [Related]
4. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.
Kräusslich HG; Hölscher C; Reuer Q; Harber J; Wimmer E
J Virol; 1990 May; 64(5):2433-6. PubMed ID: 2157900
[TBL] [Abstract][Full Text] [Related]
5. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
Marc D; Masson G; Girard M; van der Werf S
J Virol; 1990 Sep; 64(9):4099-107. PubMed ID: 2166807
[TBL] [Abstract][Full Text] [Related]
6. Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence.
Marc D; Drugeon G; Haenni AL; Girard M; van der Werf S
EMBO J; 1989 Sep; 8(9):2661-8. PubMed ID: 2555183
[TBL] [Abstract][Full Text] [Related]
7. Myristylation of picornavirus capsid protein VP4 and its structural significance.
Chow M; Newman JF; Filman D; Hogle JM; Rowlands DJ; Brown F
Nature; 1987 Jun 11-17; 327(6122):482-6. PubMed ID: 3035380
[TBL] [Abstract][Full Text] [Related]
8. Maturation of poliovirus capsid proteins.
Hellen CU; Wimmer E
Virology; 1992 Apr; 187(2):391-7. PubMed ID: 1312265
[No Abstract] [Full Text] [Related]
9. Capsid protein VP4 of poliovirus is N-myristoylated.
Paul AV; Schultz A; Pincus SE; Oroszlan S; Wimmer E
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7827-31. PubMed ID: 2825164
[TBL] [Abstract][Full Text] [Related]
10. Myristoyl modification of viral proteins: assays to assess functional roles.
Chow M; Moscufo N
Methods Enzymol; 1995; 250():495-509. PubMed ID: 7651174
[TBL] [Abstract][Full Text] [Related]
11. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
Porter DC; Ansardi DC; Morrow CD
J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
Couderc T; Hogle J; Le Blay H; Horaud F; Blondel B
J Virol; 1993 Jul; 67(7):3808-17. PubMed ID: 8389907
[TBL] [Abstract][Full Text] [Related]
13. Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.
Reynolds C; Page G; Zhou H; Chow M
Virology; 1991 Sep; 184(1):391-6. PubMed ID: 1714663
[TBL] [Abstract][Full Text] [Related]
14. Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor.
Colston E; Racaniello VR
EMBO J; 1994 Dec; 13(24):5855-62. PubMed ID: 7813425
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.
Wiegers KJ; Wetz K; Dernick R
J Virol; 1990 Mar; 64(3):1283-9. PubMed ID: 1689392
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4.
Tesar M; Jia XY; Summers DF; Ehrenfeld E
Virology; 1993 Jun; 194(2):616-26. PubMed ID: 8389076
[TBL] [Abstract][Full Text] [Related]
17. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4.
Hindiyeh M; Li QH; Basavappa R; Hogle JM; Chow M
J Virol; 1999 Nov; 73(11):9072-9. PubMed ID: 10516013
[TBL] [Abstract][Full Text] [Related]
18. A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus.
Moscufo N; Yafal AG; Rogove A; Hogle J; Chow M
J Virol; 1993 Aug; 67(8):5075-8. PubMed ID: 8392631
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
Ansardi DC; Luo M; Morrow CD
Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
[TBL] [Abstract][Full Text] [Related]
20. Myristoylation is important at multiple stages in poliovirus assembly.
Moscufo N; Simons J; Chow M
J Virol; 1991 May; 65(5):2372-80. PubMed ID: 1850017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
